AmebaGone
Business Services · Wisconsin, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
510 Charmany Dr Ste 58, Madison, Wiscons...Phone Number
(608) 216-5372Website
www.amebagone.comRevenue
<$5 MillionIndustry
About AmebaGone
AmebaGone is a biotechnology company focused on combating antimicrobial resistance through innovative technology that utilizes the natural predatory behavior of Dictyostelid amoebae. Their services include biofilm biomass assays, biofilm viability testing, and ready-to-test kits aimed at treating biofilm-associated infections. The company targets healthcare providers and researchers seeking safer alternatives to conventional antibiotics. With a diverse team of experts, AmebaGone is dedicated to developing disruptive solutions for microbial control and addressing the global health threat posed by drug-resistant infections.Explore more
AmebaGone Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to AmebaGone
Compare insights from companies similar to AmebaGone, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
AmebaGone Tech Stack
A closer look at the technologies used by AmebaGone
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding AmebaGone
Sign Up For FreeTo access detailed company insights
AmebaGone is a biotechnology company focused on combating antimicrobial resistance through innovative technology that utilizes the natural predatory behavior of Dictyostelid amoebae. Their services include biofilm biomass assays, biofilm viability testing, and ready-to-test kits aimed at treating biofilm-associated infections. The company targets h... Read More
